NASP Strategic Business Exchange to feature research poster presentation
SEATTLE – The National Association of Specialty Pharmacy will include a presentation of research posters at its inaugural Strategic Business Exchange in the fall, the group said Friday.
The presentation will provide healthcare professionals, industry experts, academics and others the opportunity to present research and interact with attendees about their findings. All accepted abstracts will be featured in Specialty Pharma Journal, an interactive online community that incorporates continuing medical education, features and departments on reimbursement, formulary protocols and risk evaluation and mitigation strategies. The exchange will take place from October 14-16 in San Antonio.
The theme of the presentation will be "Health Informatics in Pharmacy." Pharmacy informatics is a field that focuses on medication-related data and knowledge in the healthcare system, including acquisition, storage, analysis, use and dissemination. Topics for presentations can include technology and patient safety, leveraging current technologies, building a bridge of acceptance, electronic prescribing, databases paramount and point-of-care decision support.
French regulators approve Actavis-Warner Chilcott merger
PARSIPPANY, N.J. — Actavis and Warner Chilcott have received approval from all necessary antitrust clearances for their merger from regulators outside the United States, the companies said Friday.
The drug makers said that the French Competition Authority had approved U.S.-based Actavis’ acquisition of Ireland-based Warner Chilcott. The German Federal Cartel Office had previously approved the deal as well.
Actavis announced in May that it would acquire Warner Chilcott for $8.5 billion. Last month, the U.S. Federal Trade Commission requested additional information from the companies about the merger, which also had the effect of extending the waiting period required under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 until 30 days after they have complied with it. The companies said they intended to fully cooperate with the FTC and expected the deal to close in the second half of this year.
Like this story? Find us on Facebook for more insight, analysis and the latest in drug store news. Join the conversation.